投資評等
最後更新日期：2024/4/20
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/10/1 | DA Davidson | Neutral >> Buy | |
| 2010/5/11 | Stifel Nicolaus | Hold >> Buy | 57 |
| 2009/11/11 | Citigroup | Sell >> Hold | $44 >> $50 |
| 2009/8/11 | Wunderlich | Hold >> Buy | $49 >> $65 |
| 2007/6/29 | JP Morgan | Neutral Overweight | |
| 2005/5/9 | Friedman Billings | Mkt Perform->Outperform | 67 |
| 2005/4/11 | First Albany | Neutral->Buy | 68 |
| 2003/11/24 | DA Davidson | Underperform->Neutral | $37 |
| 2002/7/23 | Lehman Brothers | Buy -> Strong Buy | 43 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/12/1 | BB&T Capital Mkts | Buy >> Hold | |
| 2010/11/19 | DA Davidson | Buy >> Neutral | |
| 2010/9/14 | Standpoint Research | Buy >> Hold | |
| 2010/2/26 | Robert W. Baird | Outperform >> Neutral | $59 >> $47 |
| 2009/5/8 | Stifel Nicolaus | Buy Hold | |
| 2008/12/18 | Lazard Capital | Buy Hold | |
| 2006/5/10 | Friedman Billings | Outperform Mkt Perform | |
| 2004/12/10 | CSFB | Neutral->Underperform | |
| 2004/11/24 | First Albany | Buy->Neutral | |
| 2004/7/2 | DA Davidson | Neutral->Underperform | |
| 2003/10/30 | CSFB | Outperform -> Neutral | |
| 2003/10/30 | DA Davidson | Neutral -> Underperform | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2013/5/9 | Deutsche Bank | Buy | 84 |
| 2011/1/5 | Oppenheimer | Outperform | 84 |
| 2010/10/20 | BB&T Capital Mkts | Hold | |
| 2010/4/16 | Canaccord Adams | Buy | |
| 2009/7/7 | Wunderlich | Hold | 49 |
| 2009/6/2 | Robert W. Baird | Outperform | 60 |
| 2005/9/30 | Stanford Research | Buy | 75 |
| 2004/12/21 | JP Morgan | Neutral | |
| 2003/6/27 | Friedman Billings | Mkt Perform | 35 |
| 2003/2/7 | First Albany | Buy | 34 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2003/12/5 | Merrill Lynch | Neutral | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2013/11/25 | Barclays | Overweight | $79 >> $83 |
| 2011/5/10 | FBR Capital | Outperform | $84 >> $81 |
| 2011/4/6 | Barclays Capital | Overweight | $78 >> $86 |
| 2011/1/11 | FBR Capital | Outperform | $58 >> $84 |
| 2011/1/10 | Stifel Nicolaus | Buy | $64 >> $77 |
| 2011/1/7 | Barclays Capital | Overweight | $61 >> $78 |
| 2010/11/5 | Stifel Nicolaus | Buy | $60 >> $64 |
| 2010/7/27 | UBS | Buy | $60 >> $61 |
| 2010/7/27 | Stifel Nicolaus | Buy | $57 >> $60 |
| 2010/5/18 | UBS | Buy | $60 >> $64 |